Objectives The aim of this study is to investigate the safety and efficacy of excimer laser
coronary angioplasty (ELCA) combined with drug‐coated balloons (DCBs) in the treatment …

Background Percutaneous coronary intervention with drug-coated balloon (DCB)
angioplasty is one of the standard treatments for lesions with in-stent restenosis (ISR) …

Abstract Treatment of in-stent restenosis (ISR) is associated with a high incidence of
recurrence. This study evaluated the clinical safety and 6-month efficacy of excimer laser …

Background Treatment of in-stent restenosis (ISR) is associated with a high incidence of
recurrence. Some studies reported clinical safety and efficacy of excimer laser coronary …

Objectives. We aimed to compare the results of neointimal modification before drug‐coated
balloon (DCB) treatment with excimer laser coronary atherectomy (ELCA) plus scoring …

Background Recently, excimer laser coronary angioplasty (ELCA) with angiographic or intra
vascular ultrasound guidance failed to show its superiority over the conventional balloon …

Background Recent reports revealed that residual area stenosis (% AS)≤ 30% after lesion
preparation is a suitable predictor for target lesion revascularization (TLR) after drug-coated …

Background This study determined the clinical safety, mechanisms, and 6-month results of
excimer laser angioplasty (ELCA)+ adjunct PTCA for the treatment of in-stent restenosis and …

In-stent restenosis (ISR), when treated with balloon angioplasty (PTCA) alone, has an
angiographic recurrence rate of 30-85%. Ablating the hypertrophic neointimal tissue prior to …

Background Treatment of in-stent restenosis (ISR) is associated with a high incidence of
recurrence. This study evaluated the 1-year efficacy of excimer laser coronary angioplasty …